{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:19:00Z","timestamp":1789888740303,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijantimicag.2025.107632","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:14:05Z","timestamp":1758827645000},"page":"107632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Machine learning in antimicrobial therapy for critically ill patients: optimizing early empirical regimens, individualized dosing, and de-escalation strategies"],"prefix":"10.1016","volume":"66","author":[{"given":"Xinyun","family":"Huan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107632_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0002","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00057-2019","article-title":"Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study","volume":"54","author":"Webb","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0004","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0005","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0006","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0007","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dkac291","article-title":"Assessment of current practice for \u03b2-lactam therapeutic drug monitoring in French ICUs in 2021: a nationwide cross-sectional survey","volume":"77","author":"Tritscher","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0009","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.7326\/M19-0872","article-title":"Reporting and implementing interventions involving machine learning and artificial intelligence","volume":"172","author":"Bates","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0010","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/jac\/dkaa222","article-title":"Towards personalized guidelines: using machine-learning algorithms to guide antimicrobial selection","volume":"75","author":"Moran","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0011","doi-asserted-by":"crossref","first-page":"105221","DOI":"10.1016\/j.ebiom.2024.105221","article-title":"Optimal use of \u03b2-lactams in neonates: machine learning-based clinical decision support system","volume":"105","author":"Tang","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0012","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1093\/cid\/ciaa921","article-title":"Improving decision making in empiric antibiotic selection (IDEAS) for gram-negative bacteremia: a prospective clinical implementation study","volume":"73","author":"Elligsen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0013","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0014","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/CCM.0b013e31821b827c","article-title":"Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality","volume":"39","author":"Zahar","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0015","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis","volume":"54","author":"Micek","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0016","first-page":"477","article-title":"Appropriateness of broad spectrum antibiotics for severe sepsis and septic shock in the emergency department","volume":"99","author":"Worapratya","year":"2016","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0017","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMra2302038","article-title":"Artificial intelligence and machine learning in clinical medicine, 2023","volume":"388","author":"Haug","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0018","first-page":"43","article-title":"Using machine learning to predict antimicrobial resistance of Acinetobacter Baumannii, Klebsiella Pneumoniae and Pseudomonas Aeruginosa strains","volume":"281","author":"Feretzakis","year":"2021","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/antibiotics9020050","article-title":"Using machine learning techniques to aid empirical antibiotic therapy decisions in the intensive care unit of a General hospital in Greece","volume":"9","author":"Feretzakis","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/e21060603","article-title":"Machine learning techniques to identify antimicrobial resistance in the Intensive care unit","volume":"21","author":"Mart\u00ednez-Ag\u00fcero","year":"2019","journal-title":"Entropy."},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0021","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1093\/cid\/ciaa1576","article-title":"Predicting antibiotic resistance in hospitalized patients by applying machine learning to electronic medical records","volume":"72","author":"Lewin-Epstein","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2022.104166","article-title":"PK-RNN-V E: a deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data","volume":"133","author":"Nigo","year":"2022","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0023","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41467-024-46211-0","article-title":"Deep learning model for personalized prediction of positive MRSA culture using time-series electronic health records","volume":"15","author":"Nigo","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2021.12.002","article-title":"Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score","volume":"84","author":"Battle","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0025","article-title":"Optimising machine learning prediction of minimum inhibitory concentrations in Klebsiella pneumoniae","volume":"10","author":"Batisti Biffignandi","year":"2024","journal-title":"Microb Genom"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1320312","article-title":"Machine learning and feature extraction for rapid antimicrobial resistance prediction of Acinetobacter baumannii from whole-genome sequencing data","volume":"14","author":"Gao","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0027","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/1751-7915.13960","article-title":"Identification of antibiotic resistance and virulence-encoding factors in Klebsiella pneumoniae by Raman spectroscopy and deep learning","volume":"15","author":"Lu","year":"2022","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0028","article-title":"Discrimination between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae strains through computational analysis of surface-enhanced raman spectra: a pilot study","volume":"10","author":"Liu","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75044-6","article-title":"Repurposing MALDI-TOF MS for effective antibiotic resistance screening in Staphylococcus epidermidis using machine learning","volume":"14","author":"Ren","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/CCM.0000000000002235","article-title":"Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials","volume":"45","author":"Kalil","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0031","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/CCM.0000000000003579","article-title":"Current sepsis mandates are overly prescriptive, and some aspects may Be harmful","volume":"48","author":"Klompas","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0032","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/cid\/cix997","article-title":"Infectious diseases society of America (IDSA) POSITION STATEMENT: why IDSA did not endorse the surviving sepsis campaign guidelines","volume":"66","author":"Sepsis Task Force","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0033","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s42256-023-00638-0","article-title":"Estimating treatment effects for time-to-treatment antibiotic stewardship in sepsis","volume":"5","author":"Liu","year":"2023","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0034","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1248\/bpb.b19-00729","article-title":"A new algorithm optimized for initial dose settings of Vancomycin using machine learning","volume":"43","author":"Imai","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0036","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jphs.2022.02.005","article-title":"A machine learning model that emulates experts\u2019 decision making in vancomycin initial dose planning","volume":"148","author":"Matsuzaki","year":"2022","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154784","article-title":"Determining steady-state trough range in vancomycin drug dosing using machine learning","volume":"82","author":"Tootooni","year":"2024","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0038","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01415-23","article-title":"A machine learning approach to predict daptomycin exposure from two concentrations based on Monte Carlo simulations","volume":"68","author":"Codde","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0040","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","article-title":"On-site therapeutic drug monitoring","volume":"38","author":"Ates","year":"2020","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0041","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1208\/s12248-012-9320-2","article-title":"Covariate pharmacokinetic model building in oncology and its potential clinical relevance","volume":"14","author":"Joerger","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0042","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/bcp.14801","article-title":"Machine learning in pharmacometrics: opportunities and challenges","volume":"88","author":"McComb","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0043","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12911-022-01970-y","article-title":"Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients","volume":"22","author":"Verhaeghe","year":"2022","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0044","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40262-023-01265-z","article-title":"Use of machine learning for dosage individualization of Vancomycin in neonates","volume":"62","author":"Tang","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2147\/DDDT.S299037","article-title":"An ensemble model for prediction of Vancomycin trough concentrations in pediatric patients","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0046","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development\u2014Part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0047","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1345\/aph.1D374","article-title":"Population pharmacokinetics I: background, concepts, and models","volume":"38","author":"Ette","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0048","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cpt.1774","article-title":"Pharmacometrics and machine learning partner to advance clinical data analysis","volume":"107","author":"Koch","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0049","unstructured":"U.S. Food and Drug Administration. Population pharmacokinetics guidance for industry (DRAFT GUIDANCE). 2019."},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0051","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1093\/jac\/dkae292","article-title":"Prediction of teicoplanin plasma concentration in critically ill patients: a combination of machine learning and population pharmacokinetics","volume":"79","author":"Ma","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0052","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40262-021-01033-x","article-title":"Drug clearance in neonates: a combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction","volume":"60","author":"Tang","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0053","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10928-021-09757-w","article-title":"Fast screening of covariates in population models empowered by machine learning","volume":"48","author":"Sibieude","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0054","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/cpt.1792","article-title":"Artificial intelligence and machine learning: will clinical pharmacologists Be needed in the next decade? The John Henry question","volume":"107","author":"Corrigan","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cpt.1777","article-title":"Model-informed artificial intelligence: reinforcement learning for precision dosing","volume":"107","author":"Ribba","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0056","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/phar.2201","article-title":"Duration of exposure to antipseudomonal \u03b2-lactam antibiotics in the critically ill and development of new resistance","volume":"39","author":"Teshome","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0057","doi-asserted-by":"crossref","first-page":"dlab002","DOI":"10.1093\/jacamr\/dlab002","article-title":"Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19","volume":"3","author":"Rawson","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2023.105300","article-title":"Development of machine learning algorithms for scaling-up antibiotic stewardship","volume":"181","author":"Tran-The","year":"2024","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0059","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41467-024-44740-2","article-title":"Personalising intravenous to oral antibiotic switch decision making through fair interpretable machine learning","volume":"15","author":"Bolton","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0060","series-title":"Clinical Reasoning in the Health Professions","first-page":"89","article-title":"Factors influencing clinical decision making","author":"Smith","year":"2008"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0061","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMp1702071","article-title":"Machine learning and prediction in medicine\u2014Beyond the peak of inflated expectations","volume":"376","author":"Chen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1193282","article-title":"Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro","volume":"14","author":"Ruatta","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0063","doi-asserted-by":"crossref","DOI":"10.2196\/59587","article-title":"Data preprocessing techniques for AI and machine learning readiness: scoping review of wearable sensor data in cancer care","volume":"12","author":"Ortiz","year":"2024","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0064","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4097\/kja.20137","article-title":"Data transformation: a focus on the interpretation","volume":"73","author":"Lee","year":"2020","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/2193-1801-2-222","article-title":"Principled missing data methods for researchers","volume":"2","author":"Dong","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0066","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-85292-4_3","article-title":"Foundations of machine learning-based clinical prediction modeling: part II-generalization and overfitting","volume":"134","author":"Kernbach","year":"2022","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0067","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.spinee.2015.06.043","article-title":"Assessing calibration in an external validation study","volume":"15","author":"Collins","year":"2015","journal-title":"Spine J"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0068","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.spinee.2020.02.016","article-title":"Significance of external validation in clinical machine learning: let loose too early?","volume":"20","author":"Staartjes","year":"2020","journal-title":"Spine J"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0069","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1093\/cid\/ciaa1585","article-title":"Artificial intelligence to guide empirical antimicrobial therapy\u2013Ready for prime time?","volume":"72","author":"Van Der Werf","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0070","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1503\/cmaj.80860","article-title":"Biased data lead to biased algorithms","volume":"194","author":"Richardson","year":"2022","journal-title":"CMAJ"},{"key":"10.1016\/j.ijantimicag.2025.107632_bib0071","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.862322","article-title":"Legal and ethical consideration in artificial intelligence in healthcare: who takes responsibility?","volume":"9","author":"Naik","year":"2022","journal-title":"Front Surg"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:13:08Z","timestamp":1775517188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0924857925001876"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107632","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning in antimicrobial therapy for critically ill patients: optimizing early empirical regimens, individualized dosing, and de-escalation strategies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107632"}}